Read more: See here London is one of the U.K.'s major biotech hubs and is considered to be part of the ⁘Golden Triangle⁘ – essentially a cluster of biotech excellence – alongside Oxford and Cambridge . The capital city is a leading location for biotech activity, attracting significant investment and housing numerous companies and research institutions.
"Though Cambridge is often seen as the U.K.'s biotech capital, and Oxford has seen growth in the last five years through focused investment in world-leading research, e.g. the [COVID-19] vaccine, London benefits from housing the headquarters of many VC [venture capital] firms, banks, and global pharma companies, and attracts venture capital in the areas of AI [artificial intelligence] and biotech startups, especially," explained Adrienne Rivlin, partner in L.E.K. Consulting's healthcare practice.
In this article, we take a closer look at what makes London such a big player in the world of biotech.
No comments:
Post a Comment